NIH R01 · 2024
Exposure to per- and polyfluoroalkyl substances (PFAS) has been associated with adverse cardiometabolic health across the lifespan. Due to their widespread use in consumer and industrial products, the developing fetus, infant, and child may be exposed via transplacental transfer, breast milk, dust ingestion, diet, and drinking water. The long biological half-lives of some PFAS, which can range from 2-7 years in humans, intensifies concerns about the risk of continued exposure and associated health effects. While elevated exposure to PFAS in utero and during childhood may predispose exposed children to increased adiposity, systolic blood pressure, and cholesterol levels, the biological…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.